135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients
2021 ◽
Vol 16
(4)
◽
pp. S770-S771
J. Subramanian
◽
Y-L. Choi
◽
T-Y. Chou
◽
J. Gregg
◽
R. Hui
◽
...
2007 ◽
Vol 2
(8)
◽
pp. S509
2021 ◽
Vol 16
(4)
◽
pp. S775
J. Subramanian
◽
Y-L. Choi
◽
T-Y. Chou
◽
J. Gregg
◽
R. Hui
◽
...
Amanda Swan
◽
Zhuang Boh
◽
Ailsa Patrizio
◽
Iain Phillips
◽
Tamasin Evans
◽
...
I. Stasi
◽
A. Farnesi
◽
E. Vasile
◽
I. Petrini
◽
M. Luccchesi
◽
...
2019 ◽
Vol 12
(2)
◽
pp. 128-135
◽
2015 ◽
Vol 19
(6)
◽
pp. 734-742
◽
Kristen Kreamer
◽
Debbie Riordan
2012 ◽
Vol 131
(3)
◽
pp. E227-E235
◽
Fu-Tsai Chung
◽
Kang-Yun Lee
◽
Chih-Wei Wang
◽
Chih-Chen Heh
◽
Yao-Fei Chan
◽
...
2019 ◽
Vol 137
◽
pp. 113-122
◽
Ana C.Z. Gelatti
◽
Alexander Drilon
◽
Fernando C. Santini
2019 ◽
Vol 40
(11)
◽
pp. 1091-1098
Changbin Wang
◽
Xinzhe Dong
◽
Xiaorong Sun
◽
Ran Zhang
◽
Ligang Xing
M. Bonomi
◽
L. Bonomi
◽
M.G. Sauta
◽
A.C. Bettini
◽
M. Squadroni
◽
...
Close
Export Citation Format
Close
Share Document
Close